Items where authors include "Ciccarelli, O."

Article

Muraro, P.A. orcid.org/0000-0002-3822-1218, Kazmi, M., De Matteis, E. et al. (16 more authors) (2025) Real-world effectiveness of autologous haematopoietic stem cell transplantation for multiple sclerosis in the UK. Journal of Neurology, Neurosurgery & Psychiatry. ISSN 0022-3050

Muraro, P.A. orcid.org/0000-0002-3822-1218, Mariottini, A. orcid.org/0000-0002-1869-7067, Greco, R. orcid.org/0000-0002-6117-5328 et al. (41 more authors) (2025) Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis and neuromyelitis optica spectrum disorder — recommendations from ECTRIMS and the EBMT. Nature Reviews Neurology, 21 (3). pp. 140-158. ISSN 1759-4758

Blackstone, J., Williams, T., Nicholas, J.M. et al. (59 more authors) (2024) Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis (MS-STAT2): protocol for a multicentre, randomised controlled, double-blind, phase 3 clinical trial in the UK. BMJ Open, 14 (9). e086414. ISSN 2044-6055

Brittain, G. orcid.org/0000-0002-9903-7203, Petrie, J. orcid.org/0000-0001-6150-6724, Duffy, K.E.M. et al. (25 more authors) (2024) Efficacy and safety of autologous haematopoietic stem cell transplantation versus alemtuzumab, ocrelizumab, ofatumumab or cladribine in relapsing remitting multiple sclerosis (StarMS): protocol for a randomised controlled trial. BMJ Open, 14 (2). e083582. ISSN 2044-6055

Williams, T., John, N., Calvi, A. et al. (18 more authors) (2023) Cardiovascular risk factors in secondary progressive multiple sclerosis: A cross‐sectional analysis from the MS‐STAT2 randomized controlled trial. European Journal of Neurology, 30 (9). pp. 2769-2780. ISSN 1351-5101